🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/09/2008 | 33,99 | 34,43 | 32,84 | 33,23 | -2,36% | 4,66% | 18.179.132 |
| 29/08/2008 | 34,65 | 34,67 | 33,88 | 34,04 | -2,01% | 2,26% | 12.124.417 |
| 28/08/2008 | 34,27 | 34,90 | 34,25 | 34,73 | +1,88% | 1,89% | 9.808.546 |
| 27/08/2008 | 33,80 | 34,23 | 33,41 | 34,09 | +0,88% | 2,43% | 8.385.258 |
| 26/08/2008 | 33,38 | 34,23 | 33,25 | 33,80 | +1,20% | 2,92% | 13.519.410 |
| 25/08/2008 | 33,56 | 33,70 | 32,98 | 33,40 | -0,77% | 2,16% | 11.772.708 |
| 22/08/2008 | 33,40 | 33,88 | 33,16 | 33,65 | +1,29% | 2,17% | 10.114.038 |
| 21/08/2008 | 33,26 | 33,39 | 32,59 | 33,23 | -0,34% | 2,41% | 14.778.582 |
| 20/08/2008 | 33,64 | 33,81 | 33,11 | 33,34 | -0,88% | 2,07% | 10.150.614 |
| 19/08/2008 | 33,85 | 34,06 | 33,40 | 33,64 | -1,29% | 1,95% | 10.759.921 |
| 18/08/2008 | 34,64 | 34,83 | 33,87 | 34,07 | -1,24% | 2,75% | 8.298.064 |
| 15/08/2008 | 34,41 | 34,97 | 34,41 | 34,50 | +0,61% | 1,64% | 9.323.532 |
| 14/08/2008 | 33,99 | 34,59 | 33,65 | 34,29 | +0,56% | 2,78% | 11.555.877 |
| 13/08/2008 | 34,26 | 35,05 | 34,06 | 34,10 | -1,19% | 2,90% | 12.596.122 |
| 12/08/2008 | 33,97 | 34,68 | 33,97 | 34,51 | +0,72% | 2,08% | 12.185.620 |
| 11/08/2008 | 34,20 | 34,30 | 33,99 | 34,27 | -0,11% | 0,92% | 13.773.864 |
| 08/08/2008 | 33,31 | 34,39 | 33,02 | 34,30 | +3,07% | 4,10% | 14.812.432 |
| 07/08/2008 | 33,45 | 34,25 | 33,16 | 33,28 | -1,19% | 3,25% | 17.830.672 |
| 06/08/2008 | 33,05 | 33,93 | 32,92 | 33,68 | +1,73% | 3,06% | 14.446.261 |
| 05/08/2008 | 31,96 | 33,20 | 31,96 | 33,11 | +3,89% | 3,88% | 16.830.880 |
| 04/08/2008 | 31,78 | 32,19 | 31,44 | 31,87 | +0,42% | 2,34% | 17.054.942 |
| 01/08/2008 | 31,57 | 32,06 | 31,24 | 31,74 | +1,09% | 2,60% | 21.520.680 |
| 31/07/2008 | 31,37 | 32,26 | 31,30 | 31,39 | -0,21% | 3,07% | 18.484.519 |
| 30/07/2008 | 30,97 | 31,93 | 30,92 | 31,46 | +1,73% | 3,27% | 16.576.006 |
| 29/07/2008 | 30,61 | 30,98 | 30,11 | 30,93 | +1,09% | 2,84% | 13.714.966 |
| 28/07/2008 | 31,18 | 31,18 | 30,49 | 30,59 | -1,90% | 2,23% | 14.052.108 |
| 25/07/2008 | 30,89 | 31,49 | 30,88 | 31,18 | +1,43% | 1,98% | 14.460.933 |
| 24/07/2008 | 30,70 | 31,51 | 30,16 | 30,74 | +1,42% | 4,38% | 26.514.086 |
| 23/07/2008 | 30,24 | 30,84 | 29,78 | 30,31 | +1,40% | 3,50% | 33.357.002 |
| 22/07/2008 | 30,87 | 31,36 | 29,72 | 29,90 | -11,32% | 5,32% | 81.811.596 |